France In Vitro Diagnostics Market Outlook to 2016

Find Industry reports, Company profiles
ReportLinker and Market Statistics
>> Get this Report Now by email!

France In Vitro Diagnostics Market Outlook to 2016
Published on June 2010

Report Summary


Summary

GlobalData's new report, 'France In Vitro Diagnostics Market Outlook to 2016' provides key market data on the France In Vitro
Diagnostics (IVD) market. The report provides value (USD million), volume (units) and average price (USD) data for each segment
and sub-segment within seven market categories ' clinical chemistry, genetic testing, histology and cytology, immuno chemistry,
infectious immunology, microbiology culture, and haematology. The report also provides company shares and distribution shares data
for each of the aforementioned market categories. The report is supplemented with global corporate-level profiles of the key market
participants with information on company financials and pipeline products, wherever available.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house
analysis by GlobalData's team of industry experts.

Scope

- Market size and company share data for In Vitro Diagnostics (IVD) market categories ' clinical chemistry, genetic testing, histology
and cytology, immuno chemistry, infectious immunology, microbiology culture, and haematology.
- Annualized market revenues (USD million), volume (units) and average price (USD) data for each of the segments and
sub-segments within seven market categories. Data from 2002 to 2009, forecast forward for 7 years to 2016.
- 2009 company shares and distribution shares data for each of the seven market categories.
- Global corporate-level profiles of key companies operating within the France In Vitro Diagnostics (IVD) market.
- Key players covered include Roche, Siemens Healthcare, Abbott, Beckman Coulter, Biomerieux, Ortho-Clinical Diagnostics, and
Becton, Dickinson.

Reasons to buy

- Develop business strategies by identifying the key market categories and segments poised for strong growth.
- Develop market-entry and market expansion strategies.
- Design competition strategies by identifying who-stands-where in the France In Vitro Diagnostics (IVD) competitive landscape.
- Develop capital investment strategies by identifying the key market segments expected to register strong growth in the near future.
- What are the key distribution channels and what's the most preferred mode of product distribution ' Identify, understand and
capitalize.

Table of Content

1 Table of Contents 2
1.1 List of Tables 8

France In Vitro Diagnostics Market Outlook to 2016 (From Slideshare) Page 1/11


1.2 List of Figures 11
2 Introduction 14
2.1 What is This Report About' 14
3 In Vitro Diagnostics In France 15
3.1 In Vitro Diagnostics, Market Segmentation 15
3.2 In Vitro Diagnostics, France, Overall Revenue ($m), 2002-2016 16
3.3 In Vitro Diagnostics Market, France, Revenue Mix ($m), 2009 18
3.4 In Vitro Diagnostics Market, France, Category Contribution (%), 2009 19
3.5 In Vitro Diagnostics, France, Company Share (2008-2009) 25
4 Clinical Chemistry In France 27
4.1 Clinical Chemistry, Market Segmentation 27
4.2 Clinical Chemistry Market, France, Revenue Mix ($m), 2009 28
4.3 Clinical Chemistry Market, France, Category Contribution (%), 2009 29
4.4 Clinical Chemistry Overall Revenue (2002-2016) 30
4.4.1 Clinical Chemisty Analyzers Revenue (2002-2016) 34
4.4.2 Urine Analysis Revenue (2002-2016) 38
4.5 Clinical Chemistry Distribution Share (2008-2009) 42
4.6 Clinical Chemistry, France, Company Share (2008-2009) 43
5 Genetic Testing In France 45
5.1 Genetic Testing, Market Segmentation 45
5.2 Genetic Testing Market, France, Revenue Mix ($m), 2009 46
5.3 Genetic Testing Market, France, Category Contribution (%), 2009 47
5.4 Genetic Testing Overall Revenue (2002-2016) 48
5.5 Genetic Testing Distribution Share (2008-2009) 52
5.6 Genetic Testing, France, Company Share (2008-2009) 53
6 Haematology In France 55
6.1 Haematology, Market Segmentation 55
6.2 Haematology Market, France, Revenue Mix ($m), 2009 56
6.3 Haematology Market, France, Category Contribution (%), 2009 57
6.4 Haematology Overall Revenue (2002-2016) 58
6.4.1 Haematology Reagents Revenue (2002-2016) 62
6.4.2 Immunohaematology Revenue (2002-2016) 66
6.4.3 Haemostasis Revenue (2002-2016) 70
6.4.4 Haematology Rapid Tests Revenue (2002-2016) 74
6.4.5 Haematology Cell Counters Revenue (2002-2016) 78
6.5 Haematology Distribution Share (2008-2009) 82
6.6 Haematology, France, Company Share (2008-2009) 83
7 Histology And Cytology In France 85
7.1 Histology And Cytology, Market Segmentation 85
7.2 Histology And Cytology Market, France, Revenue Mix ($m), 2009 86
7.3 Histology And Cytology Market, France, Category Contribution (%), 2009 87
7.4 Histology And Cytology Overall Revenue (2002-2016) 88
7.4.1 Histology Revenue (2002-2016) 92
7.5 Histology And Cytology Distribution Share (2008-2009) 96
7.6 Histology And Cytology, France, Company Share (2008-2009) 97
8 Immuno Chemistry In France 99
8.1 Immuno Chemistry, Market Segmentation 99
8.2 Immuno Chemistry Market, France, Revenue Mix ($m), 2009 100



8.3 Immuno Chemistry Market, France, Category Contribution (%), 2009 101
8.4 Immuno Chemistry Overall Revenue (2002-2016) 102
8.4.1 Disease Specific Immunochemistry Revenue (2002-2016) 106
8.4.2 Drug Related Testing Revenue (2002-2016) 110
8.4.3 Endocrinology Tests Revenue (2002-2016) 114
8.4.4 Immunochemistry Analyzers Revenue (2002-2016) 118
8.5 Immuno Chemistry Distribution Share (2008-2009) 122
8.6 Immuno Chemistry, France, Company Share (2008-2009) 123
9 Infectious Immunology In France 125
9.1 Infectious Immunology, Market Segmentation 125
9.2 Infectious Immunology Market, France, Revenue Mix ($m), 2009 126
9.3 Infectious Immunology Market, France, Category Contribution (%), 2009 127
9.4 Infectious Immunology Overall Revenue (2002-2016) 128
9.5 Infectious Immunology Distribution Share (2008-2009) 132
9.6 Infectious Immunology, France, Company Share (2008-2009) 133
10 Microbiology Culture In France 135
10.1 Microbiology Culture, Market Segmentation 135
10.2 Microbiology Culture Market, France, Revenue Mix ($m), 2009 136
10.3 Microbiology Culture Market, France, Category Contribution (%), 2009 137
10.4 Microbiology Culture Overall Revenue (2002-2016) 138
10.4.1 Microbiology Analyzers Revenue (2002-2016) 142
10.5 Microbiology Culture Distribution Share (2008-2009) 146
10.6 Microbiology Culture, France, Company Share (2008-2009) 147
11 Overview of Key Companies in France In Vitro Diagnostics Market 149
11.1 F. Hoffmann-La Roche Ltd. 149
11.1.1 Company Overview 149
11.1.2 Share in the France In Vitro Diagnostics Market 149
11.2 Siemens Healthcare 150
11.3 Abbott Laboratories 151
11.4 bioMerieux S.A. 152
11.5 Beckman Coulter, Inc. 153
11.6 Ortho-Clinical Diagnostics Inc. 154
11.7 Inverness Medical Innovations, Inc. 155
11.8 Becton, Dickinson and Company 155
11.9 Bio-Rad Laboratories, Inc. 156



11.10 Hologic, Inc. 156
11.11 OLYMPUS CORPORATION 157
11.12 Mindray Medical International Limited 157
11.13 DiaSorin S.p.A 158
11.14 Qiagen N.V. 158
11.15 Gen-Probe Incorporated 159
11.16 Phadia AB 159
11.17 Sysmex Europe GmbH 160
11.18 Argene S.A. 160
11.19 Biocode Hycel 160
11.20 EUROMEDEX 161
11.21 The Elitech Group 161
12 In Vitro Diagnostics Market Pipeline Products 162
12.1 Clinical Chemisty Market Pipeline Products 162
12.2 Immuno Chemistry Market Pipeline Products 164
12.3 Haematology Market Pipeline Products 166
12.4 Infectious Immunology Market Pipeline Products 167
12.5 Microbiology Culture Market Pipeline Products 169
12.6 Histology and Cytology Market Pipeline Products 170
12.7 Genetic Testing Market Pipeline Products 171
13 Financial Deals Landscape 173
13.1 Partnerships 173
13.1.1 Diamedix Enters Into Distribution Agreement With Fumouze Diagnostics 173
13.1.2 Transgenomic Enters Into Licensing Agreement With IntegraGen 174
13.1.3 QIAGEN Enters Into Distribution Agreement With Celera 175
13.1.4 DiaGenic Enters Into Distribution Agreement With Ferrer inCode 176
13.1.5 OraSure Technologies Enters Into An Agreement With Roche Diagnostics 177
13.1.6 Royal Philips Electronics Enters Into An Agreement With bioMerieux 178
13.1.7 Technogenetics Signs Distribution Agreement With A. Menarini Diagnostics 179
13.1.8 Inverness Medical Innovations Enters Into Distribution Agreement With Epocal 180
14 Recent Developments 181
14.1 Strategy and Business Planning 181
14.1.1 Dec 08, 2009: Genetix Expands Sales, Support And Service Organization In France And Benelux 181
14.2 Product News 181
14.2.1 Jan 11, 2010: Ipsogen and Institut Curie Forms Alliance for MapQuant Dx Grade Genomic HER2 and HR Tests 181
14.2.2 Dec 03, 2009: ExonHit Launches AclarusDx Alzheimer's Test For Research Use 182



15 Appendix 183
15.1 Definitions of Markets Covered in the Report 184
15.1.1 In Vitro Diagnostics 184
15.2 Research Methodology 192
15.3 Secondary Research 193
15.4 Primary Research 193
15.5 Models 194
15.6 Forecasts 194
15.7 Expert Panels 194
15.8 GlobalData Consulting 194
15.9 Currency Conversion 195
15.10 Contact Us 195
15.11 Disclaimer 195

1.1 List of Tables
Table 1: In Vitro Diagnostics, France, Overall Revenue ($m), 2002-2016 17
Table 2: In Vitro Diagnostics Market, France, Category Contribution (%), 2009 19
Table 3: In Vitro Diagnostics, France, Cross-Category Analysis, 2002-2016 20
Table 4: In Vitro Diagnostics, France, Overall Revenue ($m), Historic, 2002-2009 22
Table 5: In Vitro Diagnostics, France, Overall Revenue ($m), Forecast, 2009-2016 24
Table 6: In Vitro Diagnostics, France, Company Share by Revenue ($m), 2008-2009 26
Table 7: Clinical Chemistry Market, France, Category Contribution (%), 2009 29
Table 8: Clinical Chemistry, France, Revenue ($m) by Segment, Historic, 2002-2009 31
Table 9: Clinical Chemistry, France, Revenue ($m) by Segment, Forecast, 2009-2016 33
Table 10: Clinical Chemisty Analyzers, France, Revenue ($m) by Sub-Segment, Historic, 2002-2009 35
Table 11: Clinical Chemisty Analyzers, France, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 37
Table 12: Urine Analysis, France, Revenue ($m) by Sub-Segment, Historic, 2002-2009 39
Table 13: Urine Analysis, France, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 41
Table 14: Clinical Chemistry, France, Distribution Share by Revenue ($m), 2008-2009 42
Table 15: Clinical Chemistry, France, Company Share by Revenue ($m), 2008-2009 44
Table 16: Genetic Testing Market, France, Category Contribution (%), 2009 47
Table 17: Genetic Testing, France, Revenue ($m) by Segment, Historic, 2002-2009 49
Table 18: Genetic Testing, France, Revenue ($m) by Segment, Forecast, 2009-2016 51
Table 19: Genetic Testing, France, Distribution Share by Revenue ($m), 2008-2009 52
Table 20: Genetic Testing, France, Company Share by Revenue ($m), 2008-2009 54
Table 21: Haematology Market, France, Category Contribution (%), 2009 57
Table 22: Haematology, France, Revenue ($m) by Segment, Historic, 2002-2009 59
Table 23: Haematology, France, Revenue ($m) by Segment, Forecast, 2009-2016 61
Table 24: Haematology Reagents, France, Revenue ($m) by Sub-Segment, Historic, 2002-2009 63
Table 25: Haematology Reagents, France, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 65
Table 26: Immunohaematology, France, Revenue ($m) by Sub-Segment, Historic, 2002-2009 67
Table 27: Immunohaematology, France, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 69
Table 28: Haemostasis, France, Revenue ($m) by Sub-Segment, Historic, 2002-2009 71
Table 29: Haemostasis, France, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 73
Table 30: Haematology Rapid Tests, France, Revenue ($m) by Sub-Segment, Historic, 2002-2009 75
Table 31: Haematology Rapid Tests, France, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 77
Table 32: Haematology Cell Counters, France, Revenue ($m) by Sub-Segment, Historic, 2002-2009 79
Table 33: Haematology Cell Counters, France, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 81



Table 34: Haematology, France, Distribution Share by Revenue ($m), 2008-2009 82
Table 35: Haematology, France, Company Share by Revenue ($m), 2008-2009 84
Table 36: Histology And Cytology Market, France, Category Contribution (%), 2009 87
Table 37: Histology And Cytology, France, Revenue ($m) by Segment, Historic, 2002-2009 89
Table 38: Histology And Cytology, France, Revenue ($m) by Segment, Forecast, 2009-2016 91
Table 39: Histology, France, Revenue ($m) by Sub-Segment, Historic, 2002-2009 93
Table 40: Histology, France, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 95
Table 41: Histology And Cytology, France, Distribution Share by Revenue ($m), 2008-2009 96
Table 42: Histology And Cytology, France, Company Share by Revenue ($m), 2008-2009 98
Table 43: Immuno Chemistry Market, France, Category Contribution (%), 2009 101
Table 44: Immuno Chemistry, France, Revenue ($m) by Segment, Historic, 2002-2009 103
Table 45: Immuno Chemistry, France, Revenue ($m) by Segment, Forecast, 2009-2016 105
Table 46: Disease Specific Immunochemistry, France, Revenue ($m) by Sub-Segment, Historic, 2002-2009 107
Table 47: Disease Specific Immunochemistry, France, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 109
Table 48: Drug Related Testing, France, Revenue ($m) by Sub-Segment, Historic, 2002-2009 111
Table 49: Drug Related Testing, France, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 113
Table 50: Endocrinology Tests, France, Revenue ($m) by Sub-Segment, Historic, 2002-2009 115
Table 51: Endocrinology Tests, France, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 117
Table 52: Immunochemistry Analyzers, France, Revenue ($m) by Sub-Segment, Historic, 2002-2009 119
Table 53: Immunochemistry Analyzers, France, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 121
Table 54: Immuno Chemistry, France, Distribution Share by Revenue ($m), 2008-2009 122
Table 55: Immuno Chemistry, France, Company Share by Revenue ($m), 2008-2009 124
Table 56: Infectious Immunology Market, France, Category Contribution (%), 2009 127
Table 57: Infectious Immunology, France, Revenue ($m) by Segment, Historic, 2002-2009 129
Table 58: Infectious Immunology, France, Revenue ($m) by Segment, Forecast, 2009-2016 131
Table 59: Infectious Immunology, France, Distribution Share by Revenue ($m), 2008-2009 132
Table 60: Infectious Immunology, France, Company Share by Revenue ($m), 2008-2009 134
Table 61: Microbiology Culture Market, France, Category Contribution (%), 2009 137
Table 62: Microbiology Culture, France, Revenue ($m) by Segment, Historic, 2002-2009 139
Table 63: Microbiology Culture, France, Revenue ($m) by Segment, Forecast, 2009-2016 141
Table 64: Microbiology Analyzers, France, Revenue ($m) by Sub-Segment, Historic, 2002-2009 143
Table 65: Microbiology Analyzers, France, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 145
Table 66: Microbiology Culture, France, Distribution Share by Revenue ($m), 2008-2009 146
Table 67: Microbiology Culture, France, Company Share by Revenue ($m), 2008-2009 148
Table 68: Clinical Chemisty Market Pipeline Products 162
Table 69: Immuno Chemistry Market Pipeline Products 164
Table 70: Haematology Market Pipeline Products 166
Table 71: Infectious Immunology Market Pipeline Products 167
Table 72: Microbiology Culture Market Pipeline Products 169
Table 73: Histology and Cytology Market Pipeline Products 170
Table 74: Genetic Testing Market Pipeline Products 171
Table 75: Diamedix Enters Into Distribution Agreement With Fumouze Diagnostics 173
Table 76: Transgenomic Enters Into Licensing Agreement With IntegraGen 174
Table 77: QIAGEN Enters Into Distribution Agreement With Celera 175
Table 78: DiaGenic Enters Into Distribution Agreement With Ferrer inCode 176
Table 79: OraSure Technologies Enters Into An Agreement With Roche Diagnostics 177
Table 80: Royal Philips Electronics Enters Into An Agreement With bioMerieux 178
Table 81: Technogenetics Signs Distribution Agreement With A. Menarini Diagnostics 179



Table 82: Inverness Medical Innovations Enters Into Distribution Agreement With Epocal 180
Table 83: USD to Local Currency, France, Average Actual Rate 2002-2009 195

1.2 List of Figures
Figure 1: In Vitro Diagnostics, Market Segmentation 15
Figure 2: In Vitro Diagnostics, France, Overall Revenue ($m), 2002-2016 16
Figure 3: In Vitro Diagnostics Market, France, Revenue Mix ($m), 2009 18
Figure 4: In Vitro Diagnostics Market, France, Category Contribution (%), 2009 19
Figure 5: In Vitro Diagnostics, France, Cross-Category Analysis, 2002-2016 20
Figure 6: In Vitro Diagnostics, France, Overall Revenue ($m), Historic, 2002-2009 21
Figure 7: In Vitro Diagnostics, France, Overall Revenue ($m), Forecast, 2009-2016 23
Figure 8: In Vitro Diagnostics, France, Company Share (%), 2009 25
Figure 9: Clinical Chemistry, Market Segmentation 27
Figure 10: Clinical Chemistry Market, France, Revenue Mix ($m), 2009 28
Figure 11: Clinical Chemistry Market, France, Category Contribution (%), 2009 29
Figure 12: Clinical Chemistry, France, Revenue ($m) by Segment, Historic, 2002-2009 30
Figure 13: Clinical Chemistry, France, Revenue ($m) by Segment, Forecast, 2009-2016 32
Figure 14: Clinical Chemisty Analyzers, France, Revenue ($m) by Sub-Segment, Historic, 2002-2009 34
Figure 15: Clinical Chemisty Analyzers, France, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 36
Figure 16: Urine Analysis, France, Revenue ($m) by Sub-Segment, Historic, 2002-2009 38
Figure 17: Urine Analysis, France, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 40
Figure 18: Clinical Chemistry, France, Company Share (%), 2009 43
Figure 19: Genetic Testing, Market Segmentation 45
Figure 20: Genetic Testing Market, France, Revenue Mix ($m), 2009 46
Figure 21: Genetic Testing Market, France, Category Contribution (%), 2009 47
Figure 22: Genetic Testing, France, Revenue ($m) by Segment, Historic, 2002-2009 48
Figure 23: Genetic Testing, France, Revenue ($m) by Segment, Forecast, 2009-2016 50
Figure 24: Genetic Testing, France, Company Share (%), 2009 53
Figure 25: Haematology, Market Segmentation 55
Figure 26: Haematology Market, France, Revenue Mix ($m), 2009 56
Figure 27: Haematology Market, France, Category Contribution (%), 2009 57
Figure 28: Haematology, France, Revenue ($m) by Segment, Historic, 2002-2009 58
Figure 29: Haematology, France, Revenue ($m) by Segment, Forecast, 2009-2016 60
Figure 30: Haematology Reagents, France, Revenue ($m) by Sub-Segment, Historic, 2002-2009 62
Figure 31: Haematology Reagents, France, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 64
Figure 32: Immunohaematology, France, Revenue ($m) by Sub-Segment, Historic, 2002-2009 66
Figure 33: Immunohaematology, France, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 68
Figure 34: Haemostasis, France, Revenue ($m) by Sub-Segment, Historic, 2002-2009 70
Figure 35: Haemostasis, France, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 72
Figure 36: Haematology Rapid Tests, France, Revenue ($m) by Sub-Segment, Historic, 2002-2009 74
Figure 37: Haematology Rapid Tests, France, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 76
Figure 38: Haematology Cell Counters, France, Revenue ($m) by Sub-Segment, Historic, 2002-2009 78
Figure 39: Haematology Cell Counters, France, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 80
Figure 40: Haematology, France, Company Share (%), 2009 83
Figure 41: Histology And Cytology, Market Segmentation 85
Figure 42: Histology And Cytology Market, France, Revenue Mix ($m), 2009 86
Figure 43: Histology And Cytology Market, France, Category Contribution (%), 2009 87
Figure 44: Histology And Cytology, France, Revenue ($m) by Segment, Historic, 2002-2009 88



Figure 45: Histology And Cytology, France, Revenue ($m) by Segment, Forecast, 2009-2016 90
Figure 46: Histology, France, Revenue ($m) by Sub-Segment, Historic, 2002-2009 92
Figure 47: Histology, France, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 94
Figure 48: Histology And Cytology, France, Company Share (%), 2009 97
Figure 49: Immuno Chemistry, Market Segmentation 99
Figure 50: Immuno Chemistry Market, France, Revenue Mix ($m), 2009 100
Figure 51: Immuno Chemistry Market, France, Category Contribution (%), 2009 101
Figure 52: Immuno Chemistry, France, Revenue ($m) by Segment, Historic, 2002-2009 102
Figure 53: Immuno Chemistry, France, Revenue ($m) by Segment, Forecast, 2009-2016 104
Figure 54: Disease Specific Immunochemistry, France, Revenue ($m) by Sub-Segment, Historic, 2002-2009 106
Figure 55: Disease Specific Immunochemistry, France, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 108
Figure 56: Drug Related Testing, France, Revenue ($m) by Sub-Segment, Historic, 2002-2009 110
Figure 57: Drug Related Testing, France, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 112
Figure 58: Endocrinology Tests, France, Revenue ($m) by Sub-Segment, Historic, 2002-2009 114
Figure 59: Endocrinology Tests, France, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 116
Figure 60: Immunochemistry Analyzers, France, Revenue ($m) by Sub-Segment, Historic, 2002-2009 118
Figure 61: Immunochemistry Analyzers, France, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 120
Figure 62: Immuno Chemistry, France, Company Share (%), 2009 123
Figure 63: Infectious Immunology, Market Segmentation 125
Figure 64: Infectious Immunology Market, France, Revenue Mix ($m), 2009 126
Figure 65: Infectious Immunology Market, France, Category Contribution (%), 2009 127
Figure 66: Infectious Immunology, France, Revenue ($m) by Segment, Historic, 2002-2009 128
Figure 67: Infectious Immunology, France, Revenue ($m) by Segment, Forecast, 2009-2016 130
Figure 68: Infectious Immunology, France, Company Share (%), 2009 133
Figure 69: Microbiology Culture, Market Segmentation 135
Figure 70: Microbiology Culture Market, France, Revenue Mix ($m), 2009 136
Figure 71: Microbiology Culture Market, France, Category Contribution (%), 2009 137
Figure 72: Microbiology Culture, France, Revenue ($m) by Segment, Historic, 2002-2009 138
Figure 73: Microbiology Culture, France, Revenue ($m) by Segment, Forecast, 2009-2016 140
Figure 74: Microbiology Analyzers, France, Revenue ($m) by Sub-Segment, Historic, 2002-2009 142
Figure 75: Microbiology Analyzers, France, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 144
Figure 76: Microbiology Culture, France, Company Share (%), 2009 147
Figure 77: F. Hoffmann-La Roche Ltd., Company Share (%),France In Vitro Diagnostics Market, 2009 149
Figure 78: Siemens Healthcare, Company Share (%),France In Vitro Diagnostics Market, 2009 150
Figure 79: Abbott Laboratories, Company Share (%),France In Vitro Diagnostics Market, 2009 151
Figure 80: bioMerieux S.A., Company Share (%),France In Vitro Diagnostics Market, 2009 152
Figure 81: Beckman Coulter, Inc., Company Share (%),France In Vitro Diagnostics Market, 2009 153
Figure 82: Ortho-Clinical Diagnostics Inc., Company Share (%),France In Vitro Diagnostics Market, 2009 154
Figure 83: GlobalData Methodology 192

Companies mentionedF. Hoffmann-La Roche Ltd.
Siemens Healthcare
Abbott Laboratories
bioMerieux S.A.
Beckman Coulter, Inc.
Ortho-Clinical Diagnostics Inc.
Inverness Medical Innovations, Inc.
Becton, Dickinson and Company



Bio-Rad Laboratories, Inc.
Hologic, Inc.
OLYMPUS CORPORATION
Mindray Medical International Limited
DiaSorin S.p.A
Qiagen N.V.
Gen-Probe Incorporated
Phadia AB
Sysmex Europe GmbH
Argene S.A.
Biocode Hycel
EUROMEDEX
The Elitech Group


Fax Order Form
To place an order via fax simply print this form, fill in the information below and fax the completed form to:
Europe, Middle East and Africa : + 33 4 37 37 15 56
Asia, Oceania and America : + 1 (805) 617 17 93
If you have any questions please visit http://www.reportlinker.com/notify/contact

Order Information
Please verify that the product information is correct and select the format(s) you require.


Product Formats
Please select the product formats and the quantity you require.

1 User License--USD 3 500.00 Quantity: _____

Site License--USD 7 000.00 Quantity: _____

Corporate License--USD 10 500.00 Quantity: _____

Contact Information
Please enter all the information below in BLOCK CAPITALS

Title: Mr Mrs Dr Miss Ms Prof

First Name: _____________________________ Last Name: __________________________________

Email Address: __________________________________________________________________________

Job Title: __________________________________________________________________________

Organization: __________________________________________________________________________

Address: __________________________________________________________________________

City: __________________________________________________________________________

Postal / Zip Code: __________________________________________________________________________

Country: __________________________________________________________________________

Phone Number: __________________________________________________________________________

Fax Number: __________________________________________________________________________


Payment Information
Please indicate the payment method, you would like to use by selecting the appropriate box.

Payment by credit card Card Number: ______________________________________________

Expiry Date __________ / _________

CVV Number _____________________

Card Type (ex: Visa, Amex…) _________________________________

Payment by wire transfer Crédit Mutuel
RIB : 10278 07314 00020257701 89
BIC : CMCIFR2A
IBAN : FR76 1027 8073 1400 0202 5770 189

Payment by check UBIQUICK SAS
16 rue Grenette – 69002 LYON, FRANCE

Customer signature:

Please note that by ordering from Reportlinker you are agreeing to our Terms and Conditions at
http://www.reportlinker.com/index/terms

Please fax this form to:

Europe, Middle East and Africa : + 33 4 37 37 15 56

Asia, Oceania and America : + 1 (805) 617 17 93


France In Vitro Diagnostics Market Outlook to 2016

Empfohlen

Empfohlen

Weitere ähnliche Inhalte

Mehr von ReportLinker.com

Mehr von ReportLinker.com (20)

France In Vitro Diagnostics Market Outlook to 2016